KALA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.32%

Insider Buying (Last 12 Months): $1,999,999.96

Insider Selling (Last 12 Months): $1,539,791.24

KALA BIO Insider Trading History Chart

KALA BIO Share Price & Price History

^$0.96

▲ +0.039 (4.22%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

KALA BIO Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/23/2025	Mark T Iwicki	Director	Sell	154,894	$0.81	$125,464.14	103,540
10/23/2025	Mary Reumuth	CFO	Sell	967	$0.82	$792.94	28,906
10/22/2025	Darius Kharabi	Insider	Sell	20,806	$0.83	$17,268.98	41,760
10/22/2025	Mary Reumuth	CFO	Sell	32,230	$0.83	$26,750.90	29,873
10/22/2025	Romulus K. Brazzell	Insider	Sell	46,748	$0.83	$38,800.84	35,952
10/22/2025	Todd Bazemore	Director	Sell	47,768	$0.83	$39,647.44	35,932
10/1/2025	Bros. Advisors Lp Baker	Major Shareholder	Sell	513,607	$1.38	$708,777.66	46,480
9/30/2025	Bros. Advisors Lp Baker	Major Shareholder	Sell	216,801	$1.60	$346,881.60	97,120
6/24/2025	Darius Kharabi	Insider	Sell	4,511	$4.01	$18,089.11	62,566
6/24/2025	Mark T Iwicki	Director	Sell	13,227	$4.01	$53,040.27	258,433
6/24/2025	Mary Reumuth	CFO	Sell	3,631	$4.01	$14,560.31	62,100
6/24/2025	Romulus K. Brazzell	Insider	Sell	5,251	$4.01	$21,056.51	82,698
6/24/2025	Todd Bazemore	Insider	Sell	4,058	$4.01	$16,272.58	83,699
6/3/2025	Darius Kharabi	Insider	Sell	730	$3.74	$2,730.20	67,077
6/3/2025	Mary Reumuth	CFO	Sell	2,850	$3.74	$10,659.00	65,731
6/3/2025	Romulus K. Brazzell	Insider	Sell	3,687	$3.74	$13,789.38	87,949
6/3/2025	Todd Bazemore	Insider	Sell	3,390	$3.74	$12,678.60	87,757
1/6/2025	Darius Kharabi	Insider	Sell	2,021	$7.63	$15,420.23	67,807
1/6/2025	Mark T Iwicki	CEO	Sell	5,779	$7.63	$44,093.77	280,076
1/6/2025	Mary Reumuth	CFO	Sell	1,706	$7.63	$13,016.78	68,581
12/30/2024	Bros. Advisors Lp Baker	Major Shareholder	Buy	310,559	$6.44	$1,999,999.96	1,083,398
6/26/2024	Mark T Iwicki	CEO	Sell	15,168	$4.75	$72,048.00	263,755
6/26/2024	Mary Reumuth	CFO	Sell	4,163	$4.75	$19,774.25	60,187
6/26/2024	Todd Bazemore	Insider	Sell	4,653	$4.75	$22,101.75	83,040
5/31/2024	Mark T Iwicki	CEO	Sell	7,392	$6.09	$45,017.28	278,923
5/31/2024	Mary Reumuth	CFO	Sell	1,786	$6.09	$10,876.74	64,350
5/31/2024	Todd Bazemore	Insider	Sell	2,093	$6.09	$12,746.37	87,693
1/4/2024	Eric Trachtenberg	Insider	Sell	1,227	$6.74	$8,269.98	68,066
1/4/2024	Mark T Iwicki	CEO	Sell	4,539	$6.73	$30,547.47	286,315
1/4/2023	Eric Trachtenberg	Insider	Sell	60	$28.55	$1,713.00	11,495
1/4/2023	Mark T Iwicki	CEO	Sell	198	$28.54	$5,650.92	45,966

SEC Filings (Institutional Ownership Changes) for KALA BIO (NASDAQ:KALA)

24.61% of KALA BIO stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

KALA BIO Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/17/2025	Woodline Partners LP	247,466	$0.38M	0.0%	-17.6%	3.525%
11/17/2025	Baker BROS. Advisors LP	985,093	$1.51M	0.0%	-18.0%	14.031%
8/15/2025	Perceptive Advisors LLC	55,227	$0.26M	0.0%	-80.1%	0.787%
8/14/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	138,556	$0.66M	0.0%	-18.9%	1.974%
8/12/2025	XTX Topco Ltd	12,990	$62K	0.0%	N/A	0.201%
8/8/2025	Geode Capital Management LLC	56,367	$0.27M	0.0%	+2.8%	0.874%
7/29/2025	AIGH Capital Management LLC	300,000	$1.43M	0.6%	+52.8%	4.651%
5/16/2025	Woodline Partners LP	258,766	$1.48M	0.0%	N/A	4.011%
5/16/2025	ADAR1 Capital Management LLC	298,955	$1.71M	0.3%	+35.7%	4.634%
5/6/2025	Readystate Asset Management LP	42,459	$0.24M	0.0%	N/A	0.658%
5/6/2025	AIGH Capital Management LLC	196,350	$1.13M	0.5%	+61.9%	3.043%
2/17/2025	Two Sigma Investments LP	11,877	$82K	0.0%	-15.2%	0.195%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	178,934	$1.24M	0.1%	+10.0%	2.938%
2/17/2025	Millennium Management LLC	136,056	$0.94M	0.0%	-3.3%	2.234%
2/17/2025	Baker BROS. Advisors LP	1,201,894	$8.34M	0.1%	+34.8%	19.736%
2/14/2025	Silverarc Capital Management LLC	231,070	$1.60M	0.4%	N/A	3.794%
2/13/2025	SR One Capital Management LP	598,940	$4.16M	1.0%	+35.0%	9.835%
2/13/2025	ADAR1 Capital Management LLC	220,373	$1.53M	0.3%	-28.0%	3.619%
2/12/2025	Geode Capital Management LLC	47,642	$0.33M	0.0%	+28.4%	0.782%
2/12/2025	AIGH Capital Management LLC	121,302	$0.84M	0.3%	N/A	1.992%
8/13/2024	SR One Capital Management LP	443,661	$3.15M	1.0%	N/A	15.755%
2/13/2024	Tower Research Capital LLC TRC	4,357	$30K	0.0%	N/A	0.162%
1/31/2024	Knights of Columbus Asset Advisors LLC	4,834	$34K	0.0%	+100.0%	0.180%
8/14/2023	Board of Trustees of The Leland Stanford Junior University	21,127	$0.31M	0.0%	+85.7%	0.832%
2/13/2023	Clear Street LLC	49,390	$1.88M	0.0%	N/A	2.888%
2/13/2023	Board of Trustees of The Leland Stanford Junior University	11,379	$0.43M	0.0%	-98.0%	0.665%
2/10/2023	Banque Cantonale Vaudoise	1,508	$58K	0.0%	-98.0%	0.088%
1/31/2023	Knights of Columbus Asset Advisors LLC	2,417	$92K	0.0%	N/A	0.141%
11/15/2022	Board of Trustees of The Leland Stanford Junior University	568,940	$0.13M	0.0%	-17.4%	37.430%
11/3/2022	Vahanian & Associates Financial Planning Inc.	207,440	$46K	0.2%	+14.4%	14.208%
8/8/2022	Integrated Wealth Concepts LLC	152,121	$46K	0.0%	+49.2%	0.210%
7/27/2022	Vahanian & Associates Financial Planning Inc.	181,384	$54K	0.2%	-68.8%	0.250%
5/11/2022	GSA Capital Partners LLP	27,185	$38K	0.0%	N/A	0.037%
5/10/2022	MAI Capital Management	72,500	$100K	0.0%	N/A	0.100%
5/9/2022	Csenge Advisory Group	20,924	$29K	0.0%	N/A	0.029%
5/9/2022	Banque Cantonale Vaudoise	75,420	$0.10M	0.0%	+30.8%	0.104%
4/27/2022	Vahanian & Associates Financial Planning Inc.	580,578	$0.80M	1.9%	-44.5%	0.800%
4/19/2022	Graypoint LLC	487,106	$0.67M	0.1%	N/A	0.671%
2/10/2022	Pictet Asset Management SA	641,009	$0.78M	0.0%	+63.5%	0.979%
2/10/2022	Rafferty Asset Management LLC	39,071	$47K	0.0%	+58.9%	0.060%
2/9/2022	BNP Paribas Arbitrage SA	445,901	$0.54M	0.0%	+4,079.0%	0.681%
2/8/2022	Northern Trust Corp	448,896	$0.54M	0.0%	-11.7%	0.685%
2/4/2022	Matisse Capital	41,400	$50K	0.0%	-26.2%	0.063%
2/2/2022	Oppenheimer & Co. Inc.	28,100	$34K	0.0%	-31.5%	0.043%
1/28/2022	Vahanian & Associates Financial Planning Inc.	1,046,484	$1.27M	1.0%	N/A	1.598%
12/10/2021	Towercrest Capital Management	122,500	$0.32M	0.1%	N/A	0.187%
11/16/2021	Caxton Corp	1,727,751	$4.53M	3.7%	+1.3%	2.659%
11/15/2021	GSA Capital Partners LLP	25,375	$66K	0.0%	N/A	0.039%
11/12/2021	Renaissance Technologies LLC	166,100	$0.44M	0.0%	N/A	0.256%
11/12/2021	Jump Financial LLC	43,500	$0.11M	0.0%	N/A	0.067%
11/12/2021	Macquarie Group Ltd.	19,498	$51K	0.0%	N/A	0.030%
11/12/2021	Oppenheimer & Co. Inc.	41,000	$0.11M	0.0%	+33.6%	0.063%
11/12/2021	Geode Capital Management LLC	933,242	$2.45M	0.0%	+23.9%	1.436%
11/10/2021	Goldman Sachs Group Inc.	154,957	$0.41M	0.0%	-3.6%	0.239%
11/10/2021	Rafferty Asset Management LLC	24,592	$64K	0.0%	N/A	0.038%
11/9/2021	Barclays PLC	34,053	$88K	0.0%	+43.3%	0.052%
11/9/2021	BlackRock Inc.	3,664,849	$9.60M	0.0%	-1.5%	5.641%
11/8/2021	State Board of Administration of Florida Retirement System	83,483	$0.22M	0.0%	+354.6%	0.128%
11/4/2021	Deutsche Bank AG	29,727	$78K	0.0%	-91.0%	0.046%
11/1/2021	SG Americas Securities LLC	25,373	$66K	0.0%	N/A	0.039%
10/27/2021	Newbridge Financial Services Group Inc.	14,216	$37K	0.0%	N/A	0.022%
10/21/2021	Virginia Retirement Systems ET AL	25,000	$66K	0.0%	N/A	0.038%
10/20/2021	Csenge Advisory Group	19,250	$53K	0.0%	N/A	0.030%
9/3/2021	Parametric Portfolio Associates LLC	175,118	$0.93M	0.0%	+22.5%	0.270%

Data available starting January 2016

KALA BIO, Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of innovative therapies for rare and severe eye diseases in the United States. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

Today's Range

Now: $0.96

$0.95

$1.72

50 Day Range

MA: $1.38

$0.62

$19.05

52 Week Range

Now: $0.96

$0.61

$20.60

Volume

179,252,385 shs

Average Volume

11,226,258 shs

Market Capitalization

$6.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of KALA BIO?: KALA BIO's top insider investors include:
Bros Advisors Lp Baker (Major Shareholder)
Mark T Iwicki (CEO)
Mark T Iwicki (Director)
Romulus K Brazzell (Insider)
Todd Bazemore (Insider)
Mary Reumuth (CFO)
Eric Trachtenberg (Insider)
Darius Kharabi (Insider)
Todd Bazemore (Director)
Learn More about top insider investors at KALA BIO.
Who are the major institutional investors of KALA BIO?: KALA BIO's top institutional shareholders include:
Baker BROS. Advisors LP — 14.03%
Woodline Partners LP — 3.52%
Learn More about top institutional investors of KALA BIO stock.
Which institutional investors are selling KALA BIO stock?: Within the previous quarter, KALA stock was sold by these institutional investors:
Baker BROS. Advisors LP
Woodline Partners LP
In the previous year, company insiders that have sold KALA BIO company stock include:
Bros Advisors Lp Baker (Major Shareholder)
Mark T Iwicki (CEO)
Mark T Iwicki (Director)
Romulus K Brazzell (Insider)
Todd Bazemore (Insider)
Mary Reumuth (CFO)
Eric Trachtenberg (Insider)
Darius Kharabi (Insider)
Learn More investors selling KALA BIO stock.